+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 1
Phase 2
Age: 19Years +
All Genders
ID04836507

Open-label Phase 12 Study of CRC01 Treatment for Adults with Relapsed or Refractory Large B-cell Lymphoma and B-cell Acute Lymphoblastic Leukemia

Led by Curocell Inc. · Updated on 2026-07-01

91

Participants Needed

2

Research Sites

6 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying the safety and effectiveness of CRC01, an investigational treatment, in adults with relapsed or refractory large B-cell lymphoma and B-cell Acute Lymphoblastic Leukemia. This multi-center phase III trial aims to assess how well CRC01 works and its tolerability in these patients who have not responded to previous therapies. Participants will first receive a conditioning chemotherapy regimen of fludarabine and cyclophosphamide. Following this, they will be given a single infusion of CRC01, which consists of chimeric antigen receptor CAR-transduced autologous T cells administered intravenously at specific target doses depending on the cohort. The study includes two cohorts with different dosing levels and will follow participants for up to five years to evaluate outcomes. During the trial, participants will be closely monitored through various assessments including laboratory tests, imaging, and evaluations of response rates, survival, and adverse events. Researchers will track the maximum tolerated dose in phase 1 and overall response and remission rates in phase 2. The study also involves long-term safety monitoring for adverse events, immunogenicity, and presence of replication-competent lentivirus, with participation lasting several years to fully assess the treatments effects.

CONDITIONS

Brief Title

Study of Efficacy and Safety of CRC01 in Adult Large B-cell Lymphoma and B-cell Acute Lymphoblastic Leukemia Patients

Research Team

B

Bom-I Kwon, BSc

G

Gunsoo Kim, MSc

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here